Zai Lab Management
Management criteria checks 3/4
Zai Lab's CEO is Samantha Du, appointed in Jan 2014, has a tenure of 10.92 years. total yearly compensation is $12.04M, comprised of 7.2% salary and 92.8% bonuses, including company stock and options. directly owns 0.46% of the company’s shares, worth $13.20M. The average tenure of the management team and the board of directors is 2.2 years and 6.3 years respectively.
Key information
Samantha Du
Chief executive officer
US$12.0m
Total compensation
CEO salary percentage | 7.2% |
CEO tenure | 10.9yrs |
CEO ownership | 0.5% |
Management average tenure | 2.2yrs |
Board average tenure | 6.3yrs |
Recent management updates
Recent updates
The Zai Lab Limited (NASDAQ:ZLAB) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Nov 15Zai Lab Limited (NASDAQ:ZLAB) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Sep 28Zai Lab (NASDAQ:ZLAB) Has Debt But No Earnings; Should You Worry?
Sep 23Shareholders May Not Be So Generous With Zai Lab Limited's (NASDAQ:ZLAB) CEO Compensation And Here's Why
Jun 12Improved Revenues Required Before Zai Lab Limited (NASDAQ:ZLAB) Stock's 50% Jump Looks Justified
May 14A Risky Bet: Zai Lab's Uncertain Future
Apr 16Lacklustre Performance Is Driving Zai Lab Limited's (NASDAQ:ZLAB) 29% Price Drop
Mar 29We're Hopeful That Zai Lab (NASDAQ:ZLAB) Will Use Its Cash Wisely
Mar 24Why Investors Shouldn't Be Surprised By Zai Lab Limited's (NASDAQ:ZLAB) Low P/S
Jan 18Here's Why We're Not Too Worried About Zai Lab's (NASDAQ:ZLAB) Cash Burn Situation
Sep 22Zai Lab Limited's (NASDAQ:ZLAB) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Jun 24We Think Zai Lab (NASDAQ:ZLAB) Can Afford To Drive Business Growth
Jun 02Is Zai Lab Limited (NASDAQ:ZLAB) Trading At A 44% Discount?
Feb 16Zai Lab (NASDAQ:ZLAB) Is In A Good Position To Deliver On Growth Plans
Jan 20CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$271m |
Jun 30 2024 | n/a | n/a | -US$298m |
Mar 31 2024 | n/a | n/a | -US$339m |
Dec 31 2023 | US$12m | US$869k | -US$335m |
Sep 30 2023 | n/a | n/a | -US$301m |
Jun 30 2023 | n/a | n/a | -US$393m |
Mar 31 2023 | n/a | n/a | -US$410m |
Dec 31 2022 | US$20m | US$830k | -US$443m |
Sep 30 2022 | n/a | n/a | -US$593m |
Jun 30 2022 | n/a | n/a | -US$529m |
Mar 31 2022 | n/a | n/a | -US$554m |
Dec 31 2021 | US$15m | US$774k | -US$704m |
Sep 30 2021 | n/a | n/a | -US$569m |
Jun 30 2021 | n/a | n/a | -US$537m |
Mar 31 2021 | n/a | n/a | -US$454m |
Dec 31 2020 | US$9m | US$689k | -US$269m |
Sep 30 2020 | n/a | n/a | -US$239m |
Jun 30 2020 | n/a | n/a | -US$240m |
Mar 31 2020 | n/a | n/a | -US$201m |
Dec 31 2019 | US$9m | US$656k | -US$195m |
Sep 30 2019 | n/a | n/a | -US$212m |
Jun 30 2019 | n/a | n/a | -US$181m |
Mar 31 2019 | n/a | n/a | -US$160m |
Dec 31 2018 | US$6m | US$638k | -US$139m |
Compensation vs Market: Samantha's total compensation ($USD12.04M) is above average for companies of similar size in the US market ($USD6.67M).
Compensation vs Earnings: Samantha's compensation has been consistent with company performance over the past year.
CEO
Samantha Du (58 yo)
10.9yrs
Tenure
US$12,042,285
Compensation
Dr. Ying Du, Ph D., also known as Samantha, serves as Founding Managing Director at Quan Capital. She served as Venture Partner at Sequoia Capital China.Dr. Du serves as an adjunct professor at Fudan Univ...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 10.9yrs | US$12.04m | 0.46% $ 13.2m | |
President & COO | 2.3yrs | US$5.55m | 0.040% $ 1.2m | |
President and Head of Global Research & Development | 1.9yrs | US$4.87m | 0.019% $ 545.5k | |
Chief Financial Officer | 1.4yrs | US$2.01m | 0.014% $ 414.1k | |
Chief Scientific Officer | 2.1yrs | no data | no data | |
Senior VP & Head of Investor Relations | 1.6yrs | no data | no data | |
Chief Legal Officer & Joint Corporate Secretary | 4.3yrs | US$5.63m | 0.027% $ 771.5k | |
Executive VP & Head of Clinical Operations | 10.9yrs | no data | no data | |
Chief Business Officer | 10.9yrs | no data | no data | |
Chief Operating Officer of R&D | 9.9yrs | no data | no data | |
Chief Commercial Officer of Greater China | less than a year | no data | no data | |
Chief Medical Officer of Oncology | 1.3yrs | no data | no data |
2.2yrs
Average Tenure
58yo
Average Age
Experienced Management: ZLAB's management team is considered experienced (2.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 10.9yrs | US$12.04m | 0.46% $ 13.2m | |
Independent Director | 4.9yrs | US$574.35k | 0.037% $ 1.1m | |
Independent Director | 7.9yrs | US$576.15k | 0.33% $ 9.7m | |
Lead Independent Director | 7.9yrs | US$608.44k | 0.063% $ 1.8m | |
Independent Director | 3.2yrs | US$570.77k | 0.049% $ 1.4m | |
Independent Director | 6.2yrs | US$567.03k | 0.049% $ 1.4m | |
Independent Director | 1.9yrs | US$821.25k | 0.017% $ 489.8k | |
Independent Director | 3.1yrs | US$564.98k | 0.023% $ 676.4k | |
Independent Director | 6.3yrs | US$557.48k | 0.044% $ 1.3m | |
Independent Director | 10.9yrs | no data | no data |
6.3yrs
Average Tenure
66.5yo
Average Age
Experienced Board: ZLAB's board of directors are considered experienced (6.3 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 11:26 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zai Lab Limited is covered by 28 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Michael Meng | BOCI Research Ltd. |
Linda Lu | BOCI Research Ltd. |
Wai Chak Yuen | BOCI Research Ltd. |